Clinical Trial Update: Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents [Phase 2]

View source ↗

Summary

Phase 2 trial in children tested cilengitide with metronomic temozolomide for relapsed or refractory high-grade gliomas and diffuse intrinsic pontine glioma and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• High-grade Glioma

Drugs mentioned

• Temozolomide (Temozolomide)
• cilengitide (cilengitide)

Snippet

Sponsor: Martin-Luther-Universität Halle-Wittenberg | Conditions: Gliomas | Phase 2 | Status: TERMINATED